- Citations, last 5 years
- 60
- Works, last 5 years
- 11
- h-index
- 51
- Scientists listed
- 1
- Grants since 2016
- 3
Grants received
2016–2019 · research · R44
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans
John A Rathmacher · Metabolic Technologies (United States) · funded by National Institutes of Health
2016–2019 · research · R44
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans
John A Rathmacher · Metabolic Technologies (United States) · funded by National Institutes of Health
2016–2018 · research · R44
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans
John A Rathmacher · Metabolic Technologies (United States) · funded by National Institutes of Health
